• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

When Should You Sell a Stock?

August 18, 2017
Phil Zeltzman, DVM, DACVS, CVJ, Fear Free Certified

Determining when to sell a stock is one of the most difficult decisions to make, not only from a financial standpoint but from an emotional standpoint as well.

Greed, hope, denial, delusion and faith are some of the emotions you need to deal with when you sell a stock. Because of these feelings, it’s much easier to buy than to sell stocks.

One way to overcome these emotions is to rely on simple math with what is called a “stop” or “stop loss.” This is the price at which you will sell a stock, regardless of what might be happening to the company or the stock market. A “trailing stop loss” is a particular type of stop loss (arguably the best type) that adjusts higher as the share price of a stock rises. This allows you to lock in profits.

It’s a great way to follow an important rule of investing: Limit your losses and preserve your profits. In other words, “cut your losers and let your winners ride.”

Let’s say you buy shares in Acme Bonegraft Company (ABC) for $50. The stock price steadily climbs to $100. That’s great, so now you need to protect your profit.

Setting up a trailing stop means that you pick a percentage, say 25 percent. If the stock price goes down by 25 percent below the highest closing price, you will sell the stock without any hesitation or hard feelings.

Remember, ABC is now worth $100 a share. So your trailing stop is $75, or 25 percent below $100. If the stock falls to $75, you sell it.

But business is good and ABC keeps climbing. It is now worth $200 a share. Your trailing stop is still 25 percent below the highest closing price, which is now $150. If the stock reaches $150 a share, you sell.

Advertisement

Sure, losing $50 per share is not fun. But because you can’t predict whether the price of ABC is going to rise to $300 or plummet to $30, you need to protect your profit. As they say on Wall Street, “nobody ever went broke taking a profit.”

Having a consistent strategy, in the form of a trailing stop, takes the guesswork out of when to sell. There is no thinking involved, no emotions, no falling in love with a particular company. When you hit your trailing stop, you sell. End of the story.

One more suggestion: instead of watching your stocks like a hawk throughout the day, watch them in the evening, after the market closes. Ideally, trailing stops should apply to closing prices, not intraday prices.

What’s so magical about the 25 percent number? Nothing. (Well, there is something, as discussed here). If a stock is very volatile, you could choose a higher trailing stop, say 33 percent. Or, if a particular stock keeps climbing and you are anxious about the market conditions, or you don’t want to risk losing 25 percent of your profits, you could set it at 20 percent, or even 10 percent.

Bottom line: 25 percent is a good compromise: It’s easy to remember, it allows some volatility, and it will always prevent a catastrophic loss.

Of course, there are many other reasons to sell a stock, but they tend to involve emotions or technical data:

  • You should sell when you realize that you made a mistake (that’s a big emotion to overcome).
  • You should sell when the price-to-earnings (P/E) ratio is insanely high (this is debatable, as a high P/E ratio may not prevent the stock price from climbing higher).
  • You should sell when the stock reaches your price target (this is tricky at best).
  • You should sell when your investment priorities have shifted (e.g., your risk tolerance decreased).
  • You should sell when the company’s fundamentals go south (e.g., profit margin, earnings, cash flow).
  • You should sell when a better opportunity comes up (this can be very subjective).

Investing is both an art and a science. Use trailing stops to take the emotion out of your investments, and your finances will be much better off.

Dr. Phil Zeltzman is a board-certified veterinary surgeon and serial entrepreneur. His traveling surgery practice takes him all over Eastern Pennsylvania and Western New Jersey. You can visit his websites at www.DrPhilZeltzman.com and www.VeterinariansInParadise.com.

Related Content:

Practice FinancesPractice Finances
Tax season tips for veterinary professionals
Tax season tips for veterinary professionals
Market research: How to find your edge
Market research: How to find your edge
A technician’s true value
A technician’s true value

Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement